Cargando…
The Second-Generation XPO1 Inhibitor Eltanexor Inhibits Human Cytomegalovirus (HCMV) Replication and Promotes Type I Interferon Response
Human cytomegalovirus (HCMV) is a ubiquitous opportunistic pathogen and can be life-threatening for immunocompromised individuals. There is currently no available vaccine for the prevention of HCMV- associated diseases and most of the available antiviral drugs that target viral DNA synthesis become...
Autores principales: | Liao, Yueyan, Ke, Xiangyu, Deng, Tianyi, Qin, Qingsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126617/ https://www.ncbi.nlm.nih.gov/pubmed/34012430 http://dx.doi.org/10.3389/fmicb.2021.675112 |
Ejemplares similares
-
Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine
por: Ke, Xiangyu, et al.
Publicado: (2020) -
Identification of Amino Acids Essential for Viral Replication in the HCMV Helicase-Primase Complex
por: Ligat, Gaetan, et al.
Publicado: (2018) -
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020) -
Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential
por: Yu, Chuan, et al.
Publicado: (2023) -
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)